139 related articles for article (PubMed ID: 6171620)
1. Hyperreactivity to myelin basic protein in multiple sclerosis.
Eggers AE; Tarmin L; Plank CR; Gamboa ET
J Neurol Sci; 1981; 52(2-3):385-90. PubMed ID: 6171620
[TBL] [Abstract][Full Text] [Related]
2. The influence of human allergic encephalitogenic peptide on cell-mediated cytotoxicity reactions in patients with multiple sclerosis.
Møller-Larsen A; Haahr S; Hansen HJ
J Neuroimmunol; 1987 Jan; 13(3):273-82. PubMed ID: 2432085
[TBL] [Abstract][Full Text] [Related]
3. Sensitization of cerebrospinal fluid and peripheral blood lymphocytes to myelin basic protein in multiple sclerosis.
Członkowska A; Półtorak M; Cendrowski W; Korlak J
Acta Neurol Scand; 1982 Jul; 66(1):121-9. PubMed ID: 6180592
[TBL] [Abstract][Full Text] [Related]
4. Antibody-dependent lymphocyte cytotoxicity against basic protein of myelin in multiple sclerosis.
Frick E; Stickl H
J Neurol Sci; 1980 May; 46(2):187-97. PubMed ID: 6155446
[TBL] [Abstract][Full Text] [Related]
5. Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study.
Reindl M; Linington C; Brehm U; Egg R; Dilitz E; Deisenhammer F; Poewe W; Berger T
Brain; 1999 Nov; 122 ( Pt 11)():2047-56. PubMed ID: 10545390
[TBL] [Abstract][Full Text] [Related]
6. Suppressed lymphoblastic response to myelin basic protein of lymphocytes from patients with multiple sclerosis.
Wicher V; Olszewski W; Milgrom F
Int Arch Allergy Appl Immunol; 1979; 59(1):49-57. PubMed ID: 87376
[No Abstract] [Full Text] [Related]
7. Cell-mediated cytotoxicity by peripheral blood lymphocytes against basic protein of myelin, encephalitogenic peptide, cerebrosides and gangliosides in multiple sclerosis.
Frick E
J Neurol Sci; 1982; 57(1):55-66. PubMed ID: 6185643
[TBL] [Abstract][Full Text] [Related]
8. Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis.
Zhang J; Markovic-Plese S; Lacet B; Raus J; Weiner HL; Hafler DA
J Exp Med; 1994 Mar; 179(3):973-84. PubMed ID: 7509366
[TBL] [Abstract][Full Text] [Related]
9. [Pathogenesis of multiple sclerosis. Antibody dependent cytotoxicity of lymphocytes against myelin basic proteins in multiple sclerosis].
Frick E; Stickl H
Fortschr Med; 1977 Oct; 95(37):2235-41. PubMed ID: 914178
[TBL] [Abstract][Full Text] [Related]
10. Optic neuritis and multiple sclerosis. Cell-mediated cytotoxicity by peripheral blood lymphocytes against basic protein of myelin, encephalitogenic peptide, cerebrosides and gangliosides.
Frick E
Eur Neurol; 1988; 28(3):120-5. PubMed ID: 2454817
[TBL] [Abstract][Full Text] [Related]
11. Cellular hypersensitivity to gangliosides and myelin basic protein in multiple sclerosis.
Ilyas AA; Davison AN
J Neurol Sci; 1983 Apr; 59(1):85-95. PubMed ID: 6189970
[TBL] [Abstract][Full Text] [Related]
12. Clonal depletion of human myelin basic protein-reactive T-cells by T-cell vaccination.
Zhang J; Raus J
Ann N Y Acad Sci; 1995 Jul; 756():323-6. PubMed ID: 7544083
[No Abstract] [Full Text] [Related]
13. Lymphocyte sensitization to basic protein of brain in multiple sclerosis and other neurological diseases.
Caspary EA; Field EJ
J Neurol Neurosurg Psychiatry; 1974 Jun; 37(6):701-3. PubMed ID: 4135820
[TBL] [Abstract][Full Text] [Related]
14. [Enzyme-linked immunoadsorbent assays for myelin basic protein and antibodies to myelin basic protein in serum and CSF of patients with diseases of the nervous system].
Wang R; Chen J; Zhou S; Li C; Yuan G; Xu W; Wang X; Li J; Song Y; Gong N
Hua Xi Yi Ke Da Xue Xue Bao; 1995 Jun; 26(2):131-4. PubMed ID: 7490015
[TBL] [Abstract][Full Text] [Related]
15. Cell-mediated hypersensitivity in multiple sclerosis and other neurological diseases.
Minderhoud JM; Mourik J; Teelken AW
Clin Neurol Neurosurg; 1977; 80(1):22-32. PubMed ID: 73438
[TBL] [Abstract][Full Text] [Related]
16. Age-related reactivity of lymphocytes from multiple sclerosis patients to myelin basic protein.
Wicher V; Olszewski W; Milgrom F
Int Arch Allergy Appl Immunol; 1981; 66(2):136-41. PubMed ID: 6169648
[TBL] [Abstract][Full Text] [Related]
17. Multiple sclerosis-lymphocyte transformation with multiple sclerosis and normal brain myelin basic protein and subcellular fractions.
Hughes RA; Gray IA; Gregson NA; Metcalfe RA
Acta Neurol Scand; 1982 Mar; 65(3):161-73. PubMed ID: 6177188
[TBL] [Abstract][Full Text] [Related]
18. Immunological studies of the pathogenesis of multiple sclerosis. Cell-mediated cytotoxicity by peripheral blood lymphocytes against basic protein of myelin, encephalitogenic peptide, cerebrosides and gangliosides.
Frick E
Acta Neurol Scand; 1989 Jan; 79(1):1-11. PubMed ID: 2467501
[TBL] [Abstract][Full Text] [Related]
19. Spinal fluid basic protein immunoreactive material and spinal fluid lymphocyte reactivity to basic protein.
Lisak RP; Zweiman B; Whitaker JN
Neurology; 1981 Feb; 31(2):180-2. PubMed ID: 6162132
[TBL] [Abstract][Full Text] [Related]
20. Multiple sclerosis: sensitization of a myelin basic protein fragment (peptide T) encephalitogenic to primates. A preliminary report.
Sheremata W; Eylar EH; Cosgrove JB
J Neurol Sci; 1977 Jun; 32(2):255-63. PubMed ID: 69018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
